Original news and analysis on international IP policy
Patents are often involved in public health policy discussions, and are considered by some as playing a major role in the escalating prices of new medicines, creating access issues. The World Intellectual Property Organization committee on patent law this week is discussing the issue and is holding information sessions by the Medicines Patent Pool, World Health Organization, and the World Trade Organization.
The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications.
According to delegates speaking at the first plenary of the 11th Ministerial Meeting of the World Trade Organization in Buenos Aires today, member states face the risk of leaving with no joint agreement at all. For the much-debated e-commerce file for example there are eight different and irreconcilable proposals, the South African Ambassador Xavier Charm, chairman of the General Council, reported during the Welcome Session Sunday evening.
The first biosimilar of the blockbuster breast cancer drug trastuzumab is being prepared for launch in United States, following a decision by the Food and Drug Administration (FDA) to approve it earlier this month. The product, Ogivri, has been created by a joint venture between US Mylan and Indian company Biocon.
The European Patent Office (EPO) today announced a study that showed "European patent applications related to smart connected objects are rising rapidly, achieving a growth rate of 54% in the last three years."
The World Intellectual Property Organization Committee on Development and Intellectual Property in its latest meeting agreed on a list of items to be discussed at its next session. No consensus was found on a potential biennial conference on IP and development, but discussions are set to continue. The committee also agreed to a suggestion to invite the team conducting an independent review on the implementation of the Development Agenda Recommendations to further explain some of their own recommendations.
NEW YORK -- A panel at the recent IP Dealmakers Forum including a US Federal Trade Commission official, a former US judge on a key patent case, and a telecommunications industry licensing expert walked through issues and prospects for the coming of the 5G next generation wireless technology. Views differed on points but panellists agreed that changes are needed to the system for standard-essential patents, including a bigger role for standard-setting organisations. Below is an in-depth account of the discussion. The discussion also included the latest state-of-play at the FTC, which currently has its lowest number of commissioners ever.
A new European Union ancillary copyright provision for news publishers will help them against news aggregators and platform providers, promised proponents and two panellists favouring the addition of the EU Copyright Reform at a workshop of the Justice Committee (JURI) of the European Parliament in Brussels today (7 December). But it’s a promise that cannot be kept according to a study commissioned by the Parliament and also presented during a feisty discussion at the workshop.
Should the European Parliament consider regulation on 3D printing with regard to intellectual property protection and civil liability? Members of the Justice Committee (JURI) today at their session in Brussels were divided with representatives from the Green Party group as well as the conservatives and liberals cautioning against erecting barriers to the technology.
In an extraordinary 6 December session, the UN International Labour Organization Administrative Tribunal (ILOAT) handed down five decisions involving the European Patent Office (EPO), one of which reinstated a suspended Board of Appeals judge. The cases are just “the tip of the iceberg,” said the Staff Union of the EPO (SUEPO).
Innovators around the world filed 3.1 million patent applications in 2016, up 8.3 percent in a seventh straight yearly increase, WIPO’s annual World Intellectual Property Indicators (WIPI) report shows. The report, WIPO’s annual report, released at the United Nations in Geneva today, showed China topping patent, trademark and design filings in 2016.
What do investment, trade, intellectual property, health financing, R&D, industrial and medicines regulation policy have in common? They are all important building blocks for the successful promotion of local pharmaceutical manufacturing. As more and more countries are looking into building their own pharmaceutical production capacities, they need to ensure strong policy coherence to be successful.